Loading...
Loading...
Loading tenders...
Estimated Value
Not disclosed
Deadline
Not specified
Contract Period
Not specified
Procurement Method
open
Extracted from the notice; check the official documents.
Queen’s University Belfast - The Future Medicines Institute (FMI) intends to procure a peptide synthesis solution comprising equipment, associated consumables, and appropriate maintenance and support arrangements to enable in house peptide synthesis capability. • Establishment of a reliable, in house peptide synthesis capability aligned to research delivery requirements. • Provision of supplier support, including training, to ensure competent and effective operation by authorised users. • Delivery of scalable synthesis capability to support routine generation of short peptides and time efficient synthesis of longer peptide sequences. • Enablement of consistent, reproducible outputs to meet ongoing and future research needs. The Future Medicines Institute (FMI) is focused on the identification and development of novel therapeutics and diagnostic approaches. The required capability will support experimental workflows by enabling the generation of peptide materials essential to underpin these research activities, contributing to institutional strategic objectives in advanced therapeutics. The solution is expected to support broader academic use, enabling access across relevant research groups and maximising utilisation. This will facilitate collaborative research activity and enhance overall institutional research capability and impact.
Value not stated · Award decision 14 Sept 2026 (contract not yet signed) · Contract ends 23 Sept 2031 · Award notice ↗
From award notices on Find a Tender and Contracts Finder. SME or Large is the size the supplier declared on the notice (or, where it is silent, on its latest notice). Values are as published.